iZafe Group AB (publ) (STO:IZAFE.B)
0.3860
-0.0080 (-2.03%)
Jun 10, 2026, 12:34 PM CET
iZafe Group AB Revenue
iZafe Group AB had revenue of 2.42M SEK in the quarter ending March 31, 2026, with 83.54% growth. This brings the company's revenue in the last twelve months to 7.09M, up 20.98% year-over-year. In the year 2025, iZafe Group AB had annual revenue of 5.99M, down -24.68%.
Revenue (ttm)
7.09M
Revenue Growth
+20.98%
P/S Ratio
23.92
Revenue / Employee
644.73K
Employees
11
Market Cap
169.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.99M | -1.96M | -24.68% |
| Dec 31, 2024 | 7.95M | 6.13M | 336.55% |
| Dec 31, 2023 | 1.82M | 1.09M | 149.93% |
| Dec 31, 2022 | 729.00K | 287.00K | 64.93% |
| Dec 31, 2021 | 442.00K | -9.05M | -95.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AddLife AB | 10.39B |
| Synsam AB | 7.13B |
| Dynavox Group AB | 2.47B |
| Bonesupport Holding AB | 1.22B |
| Stille AB | 617.41M |
| Bio-Works Technologies AB | 83.23M |
| Ortivus AB | 76.75M |
| S2Medical AB | 16.13M |
iZafe Group AB News
- 6 weeks ago - iZafe Group AB Quarterly report: Q1 2026 - Filings
- 4 months ago - iZafe Group AB Quarterly report: Q3 2025 - Filings
- 4 months ago - iZafe Group AB Quarterly report: Q4 2025 - Filings
- 4 months ago - iZafe Group AB Annual report: Q4 2025 - Filings
- 7 months ago - iZafe Group AB Quarterly report: Q3 2025 - Filings
- 10 months ago - iZafe Group AB Quarterly report: Q2 2025 - Filings